ENSYSCE BIOSCIENCES, INC. Adjustments to Additional Paid in Capital, Other
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Adjustments to Additional Paid in Capital, Other of $26.09 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-05-15
- ENSYSCE BIOSCIENCES, INC. adjustments to additional paid in capital, other for the quarter ending 2025-03-31 was $26.09K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month |
|---|---|
| 2025-03-31 | $26.09K 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |